In vivo antidiabetic activity and in silico studies on adenosine monophosphate-activated protein kinase (AMPK) of (2E,5E)-2,5-bis(4-hydroxy-3-methoxybenzylidene) cyclopentanone
- 6 October 2012
- journal article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 22 (5) , 2430-2436
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical ConsiderationsThe Review of Diabetic Studies, 2009
- 2,5-Bis(3,4-dimethoxybenzylidene)cyclopentanoneActa Crystallographica Section E Crystallographic Communications, 2007
- Hypoglycemic and Antihyperglycemic Effect of Gmelina asiatica LINN. in Normal and in Alloxan Induced Diabetic RatsBiological and Pharmaceutical Bulletin, 2005
- MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometriesJournal of Computational Chemistry, 1999
- MMFF VI. MMFF94s option for energy minimization studiesJournal of Computational Chemistry, 1999
- Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rulesJournal of Computational Chemistry, 1996
- Merck molecular force field. IV. conformational energies and geometries for MMFF94Journal of Computational Chemistry, 1996
- Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94Journal of Computational Chemistry, 1996
- Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactionsJournal of Computational Chemistry, 1996
- ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformationJournal of Computational Chemistry, 1994